EV Biologics, Inc. (OTCMKTS:YECO – Get Free Report)’s share price shot up 28.5% during trading on Wednesday . The company traded as high as $0.13 and last traded at $0.13. 41,000 shares changed hands during mid-day trading, an increase of 271% from the average session volume of 11,050 shares. The stock had previously closed at $0.10.
EV Biologics Trading Down 18.6 %
The company has a fifty day moving average price of $0.15 and a 200 day moving average price of $0.22.
EV Biologics Company Profile
EV Biologics, Inc, a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces.
See Also
- Five stocks we like better than EV Biologics
- What Does Downgrade Mean in Investing?
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What Are Treasury Bonds?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- 3 Monster Growth Stocks to Buy Now
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for EV Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EV Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
